Correlation Between Structure Therapeutics and Cadrenal Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Structure Therapeutics and Cadrenal Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Structure Therapeutics and Cadrenal Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Structure Therapeutics American and Cadrenal Therapeutics, Common, you can compare the effects of market volatilities on Structure Therapeutics and Cadrenal Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Structure Therapeutics with a short position of Cadrenal Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Structure Therapeutics and Cadrenal Therapeutics,.
Diversification Opportunities for Structure Therapeutics and Cadrenal Therapeutics,
-0.14 | Correlation Coefficient |
Good diversification
The 3 months correlation between Structure and Cadrenal is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding Structure Therapeutics America and Cadrenal Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cadrenal Therapeutics, and Structure Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Structure Therapeutics American are associated (or correlated) with Cadrenal Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cadrenal Therapeutics, has no effect on the direction of Structure Therapeutics i.e., Structure Therapeutics and Cadrenal Therapeutics, go up and down completely randomly.
Pair Corralation between Structure Therapeutics and Cadrenal Therapeutics,
Given the investment horizon of 90 days Structure Therapeutics is expected to generate 3.86 times less return on investment than Cadrenal Therapeutics,. But when comparing it to its historical volatility, Structure Therapeutics American is 1.72 times less risky than Cadrenal Therapeutics,. It trades about 0.12 of its potential returns per unit of risk. Cadrenal Therapeutics, Common is currently generating about 0.26 of returns per unit of risk over similar time horizon. If you would invest 1,550 in Cadrenal Therapeutics, Common on November 3, 2024 and sell it today you would earn a total of 427.00 from holding Cadrenal Therapeutics, Common or generate 27.55% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Structure Therapeutics America vs. Cadrenal Therapeutics, Common
Performance |
| Timeline |
| Structure Therapeutics |
| Cadrenal Therapeutics, |
Structure Therapeutics and Cadrenal Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Structure Therapeutics and Cadrenal Therapeutics,
The main advantage of trading using opposite Structure Therapeutics and Cadrenal Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Structure Therapeutics position performs unexpectedly, Cadrenal Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cadrenal Therapeutics, will offset losses from the drop in Cadrenal Therapeutics,'s long position.| Structure Therapeutics vs. Day One Biopharmaceuticals | Structure Therapeutics vs. X4 Pharmaceuticals | Structure Therapeutics vs. Inozyme Pharma | Structure Therapeutics vs. Acumen Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |